Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients

Clinical trial NCT01395056 · COMPLETED

Trial details

NCT number: NCT01395056
Sponsor: Peking University Cancer Hospital & Institute
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Neoplasms Neoplasm Metastasis

Start date: 2011-07-01
Primary completion: 2014-12-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.